headache
Research Papers
Showing 6 of 10Neuroscience Education as Therapy for Migraine and Overlapping Pain Conditions: A Scoping Review
BACKGROUND: Neuroscience education therapy (NET) has been successfully used for numerous overlapping pain conditions, but few studies have investigated NET for migraine. OBJECTIVE: We sought to 1) review the literature on NET used for the treatment of various pain conditions to assess how NET has been studied thus far and 2) recommend considerations for future research of NET for the treatment of migraine. DESIGN/METHODS: Following the PRISMA guideline for scoping reviews, co-author (TR), a medical librarian, searched the MEDLINE, PsychInfo, Embase, and Cochrane Central Clinical Trials Registry databases for peer-reviewed articles describing NET to treat migraine and other chronic pain conditions. Each citation was reviewed by two trained independent reviewers. Conflicts were resolved through consensus. RESULTS: Overall, a NET curriculum consists of the following topics: pain does not equate to injury, pain is generated in the brain, perception, genetics, reward systems, fear, brain plasticity, and placebo/nocebo effects. Delivered through individual, group, or a combination of individual and group sessions, NET treatments often incorporate exercise programs and/or components of other evidence-based behavioral treatments. NET has significantly reduced catastrophizing, kinesiophobia, pain intensity, and disability in overlapping pain conditions. In migraine-specific studies, when implemented together with traditional pharmacological treatments, NET has emerged as a promising therapy by reducing migraine days, pain intensity and duration, and acute medication intake. CONCLUSION: NET is an established treatment for pain conditions, and future research should focus on refining NET for migraine, examining delivery modality, dosage, components of other behavioral therapies to integrate, and migraine-specific NET curricula.
View Full Paper →Passive Infrared Hemoencephalography (pIR HEG) for the Treatment of Migraine without Aura
Objective: To evaluate the impact of Passive Infrared Hemoencephalography (pIR HEG) in reducing headacherelated disability in adults with migraine without aura (MWOA). Methods: This quasi-experimental study enrolled 31 adults (M age = 38.65 years, range = 20-65 years) who met the International Classification of Headache Disorders (2nd ed.) criteria for migraine without aura (MWOA; IHS, 2004). All participants received the treatment. Participants completed a 10-week protocol of pIR HEG. Changes in headache impact were assessed at three points in time: baseline, after six treatment sessions, and after 10 treatment sessions. Outcome Measures: Headache Impact Test (HIT-6) and the Migraine Disability Assessment (MIDAS) questionnaire. Results: Significant reductions in HIT-6 scores were found between Pretest and Midtreatment, p < .001, and between Pretest and Posttest, p < .001. Significant reductions in MIDAS scores were found between Pretest and Posttest, p < .001. Results indicated MIDAS subscale A scores did not significantly change across the three time points. Significant reductions in MIDAS subscale B scores were found between Pretest and Midtreatment, p < .001, and between Pretest and Posttest, p < .001. In this study, pIR HEG appeared to be effective by the end of treatment in reducing the impact of headache-related disability among the participants.
View Full Paper →Clinical Advantages of Quantitative Electroencephalogram (QEEG)–Electrical Neuroimaging Application in General Neurology Practice
QEEG-electrical neuroimaging has been underutilized in general neurology practice for uncertain reasons. Recent advances in computer technology have made this electrophysiological testing relatively inexpensive. Therefore, this study was conducted to evaluate the clinical usefulness of QEEG/electrical neuroimaging in neurological practice. Over the period of approximately 6 months, 100 consecutive QEEG recordings were analyzed for potential clinical benefits. The patients who completed QEEG were divided into 5 groups based on their initial clinical presentation. The main groups included patients with seizures, headaches, post-concussion syndrome, cognitive problems, and behavioral dysfunctions. Subsequently, cases were reviewed and a decision was made as to whether QEEG analysis contributed to the diagnosis and/or furthered patient’s treatment. Selected and representative cases from each group are presented in more detail, including electrical neuroimaging with additional low-resolution electromagnetic tomography analysis or using computerized cognitive testing. Statistical analysis showed that QEEG analysis contributed to 95% of neurological cases, which indicates great potential for wider application of this modality in general neurology. Many patients also began neurotherapy, depending on the patient’s desire to be involved in this treatment modality.
View Full Paper →LORETA Neurofeedback: Odd Reports, Observations, and Findings Associated with Spatial Specific Neurofeedback Training
Neurotherapeutic techniques continue to advance in sophistication and complexity, and as such so does the need to reference odd occurrences or adverse reactions as a result of training in different regions of the brain. This is important to the field of neurotherapy in addition to those practitioners who may encounter patients on medications at the time of training, and this type of information can only add to the armamentarium of tools at our disposal. We discuss noted odd occurrences that have transpired during our studies employing LORETA neurofeedback (LNFB) in both children and adults. We also discuss negative events reported by patients or parents and medications interactions with LNFB. Positive results are also discussed. The field of neurofeedback can benefit immensely from more reports of this type.
View Full Paper →What is Neurofeedback: An Update
Written to educate both professionals and the general public, this article provides an update and overview of the field of neurofeedback (EEG biofeedback). The process of assessment and neurofeedback training is explained. Then, areas in which neurofeedback is being used as a treatment are identified and a survey of research findings is presented. Potential risks, side effects, and adverse reactions are cited and guidelines provided for selecting a legitimately qualified practitioner.
View Full Paper →Passive Infrared Hemoencephalography: Four Years and 100 Migraines
Background. One hundred migraine sufferers were treated using passive Infrared Hemoencephalography (pIR HEG) over a period of four years. All subjects met the criteria for at least one of the categories set forth in the International Headache Society (IHS, 1988) classification criteria for headache disorders for primary migraine. Methods. Subjects were treated using the pIR HEG system in 30-minute sessions. A central forehead placement (approximately Fpz) was used for the sensor assembly for all subjects. Changes in headache patterns were examined. After two years, an infrared video imaging system was added to the data collection process and was available for 61 of the 100 subjects. Infrared forehead images were captured at the start and end of each session to examine changes in prefrontal cortical brain activity. Results. Most of the subjects improved control over their migraine headaches. Over 90% of those subjects who completed at least six sessions reported significant improvements in migraine activity. Conclusions. pIR HEG appears to have a strong impact on migraine headaches, even for people who have not had a positive response to medication. Headache response by the end of six sessions appears to be a good predictor of probability of improvement
View Full Paper →Ready to Optimize Your Brain?
Schedule a free consultation to discuss headache and how neurofeedback training can help
Or call us directly at 855-88-BRAIN
View Programs & Pricing →